Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ATNM on NYSE
Shares outstanding
31,249,203
Price per share
$1.43
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
5,410,599
Total reported value
$7,356,463
% of total 13F portfolios
0%
Share change
+274,051
Value change
+$328,393
Number of holders
58
Price from insider filings
$1.43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 4.4% $1,920,576 1,371,840 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 1.5% $646,490 462,969 BlackRock, Inc. 30 Jun 2025

As of 31 Dec 2025, 58 institutional investors reported holding 5,410,599 shares of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM). This represents 17% of the company’s total 31,249,203 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) together control 17% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.5% 1,421,038 +2.6% 0% $1,932,611
ACADIAN ASSET MANAGEMENT LLC 1.9% 606,339 +24% 0% $823,000
MILLENNIUM MANAGEMENT LLC 1.9% 601,600 -3.7% 0% $818,176
RENAISSANCE TECHNOLOGIES LLC 1.3% 390,784 +35% 0% $531,466
BlackRock, Inc. 1.2% 366,931 +0.95% 0% $499,026
GEODE CAPITAL MANAGEMENT, LLC 1.1% 328,994 +0.18% 0% $447,564
TWO SIGMA INVESTMENTS, LP 0.67% 209,692 -11% 0% $285,181
GAGNON SECURITIES LLC 0.65% 201,807 -11% 0.06% $274,458
TWO SIGMA ADVISERS, LP 0.63% 196,076 -0.15% 0% $266,663
STATE STREET CORP 0.4% 126,215 0% 0% $171,652
Gen-Wealth Partners Inc 0.34% 107,131 -2.1% 0.05% $145,698
JANE STREET GROUP, LLC 0.3% 93,192 +0.18% 0% $126,742
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.26% 82,474 -22% 0% $112,165
GOLDMAN SACHS GROUP INC 0.23% 70,358 0% $95,687
Squarepoint Ops LLC 0.21% 65,730 0% $89,393
BAILARD, INC. 0.19% 57,867 0% $78,699
NORTHERN TRUST CORP 0.14% 42,610 +19% 0% $57,950
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.13% 40,000 0% 0% $54,400
DIMENSIONAL FUND ADVISORS LP 0.11% 34,923 0% 0% $47,495
Vontobel Holding Ltd. 0.1% 30,000 0% 0% $40,800
AM INVESTMENT STRATEGIES LLC 0.09% 29,356 0.01% $40,000
XTX Topco Ltd 0.08% 25,976 +30% 0% $35,327
Callan Family Office, LLC 0.08% 23,603 0% 0% $32,100
MAYPORT, LLC 0.07% 22,000 0% 0.01% $29,920
OSAIC HOLDINGS, INC. 0.06% 20,265 +183% 0% $27,560

Institutional Holders of Actinium Pharmaceuticals, Inc. - Common Stock (ATNM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,410,599 $7,356,463 +$328,393 $1.36 58
2025 Q3 5,146,844 $8,234,489 -$424,552 $1.60 60
2025 Q2 5,475,849 $7,665,146 -$4,035,323 $1.40 62
2025 Q1 8,198,200 $13,196,751 +$237,439 $1.61 69
2024 Q4 8,134,174 $10,248,048 -$913,574 $1.26 69
2024 Q3 8,459,139 $15,901,857 -$617,206 $1.88 71
2024 Q2 7,246,907 $53,627,942 +$3,426,497 $7.40 73
2024 Q1 6,729,352 $52,695,053 +$7,761,585 $7.83 65
2023 Q4 5,758,372 $29,252,507 -$58,635 $5.08 59
2023 Q3 5,762,849 $34,114,400 -$1,202,051 $5.92 58
2023 Q2 6,040,790 $44,822,973 +$8,382,914 $7.42 69
2023 Q1 4,756,784 $44,950,334 +$1,894,131 $9.45 65
2022 Q4 4,488,300 $47,826,517 +$17,470,046 $10.65 59
2022 Q3 2,863,634 $21,129,560 +$2,886,294 $7.38 46
2022 Q2 2,464,649 $11,852,572 +$2,944,615 $4.81 39
2022 Q1 1,829,833 $9,346,008 -$539,334 $5.11 32
2021 Q4 1,908,876 $11,473,412 -$433,272 $6.01 33
2021 Q3 1,932,424 $17,120,867 +$1,950,325 $8.86 39
2021 Q2 1,727,482 $13,663,637 +$3,303,864 $7.91 31
2021 Q1 1,310,290 $9,986,632 -$5,421,678 $7.62 33
2020 Q4 2,003,580 $15,628,122 -$4,777,521 $7.80 43
2020 Q3 2,385,295 $23,109,542 +$23,097,542 $9.69 36
2020 Q2 3,868 $13,000 $4.22 2
2020 Q1 1,498 $12,000 $8.01 1
2019 Q4 3,868 $13,000 $4.22 2
2019 Q3 1,498 $12,000 $8.01 1
2019 Q2 1,498 $12,000 $8.01 1
2019 Q1 1,498 $12,000 $8.01 1